Zelira Therapeutics Issues 3.5 Million Convertible Notes

Zelira Therapeutics (AU:ZLD) has released an update.

Pick the best stocks and maximize your portfolio:

Zelira Therapeutics Limited has announced the issuance of 3.5 million unquoted convertible notes as part of previously disclosed transactions. These securities are not intended to be quoted on the Australian Securities Exchange. Investors may find this development indicative of the company’s strategic financial maneuvers.

For further insights into AU:ZLD stock, check out TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.